ZYDUS LIFESCIENCES Fact Sheet, ZYDUS LIFESCIENCES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES Fact Sheet   (CADIL)


Find Out: How to Find One Stock with Crorepati Potential?


Here is the latest financial fact sheet of ZYDUS LIFESCIENCES. For more details, see the ZYDUS LIFESCIENCES quarterly results and ZYDUS LIFESCIENCES share price and chart. For a sector overview, read our pharmaceuticals sector report.

ZYDUS LIFESCIENCES Price History

Price Rs 353.7
Mkt Cap Rs m 362,098
Vol '000 15.2
P/E X 17.5
P/CF X 12.7
EPS (TTM) Rs 20.2
1 Day % 2.2
No. of shares m 1,023.74
1 Week % 3.2
1 Month % -2.4
1 Year % -43.3
52 week H/L Rs 655.0/319.4
As on Jun 24, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ZYDUS LIFESCIENCES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ZYDUS LIFESCIENCES EQUITY SHARE DATA
High Rs460558432352509 
Low Rs305362306207259 
Sales per share (Unadj.) Rs89.7116.3128.6139.2147.5 
Earnings per share (Unadj.) Rs14.517.118.111.520.9 
Diluted earnings per shareRs14.517.118.111.520.9 
Cash flow per share (Unadj.) Rs18.122.323.918.328.0 
Dividends per share (Unadj.) Rs3.203.503.503.503.50 
Adj. dividends per shareRs3.203.503.503.503.50 
Avg Dividend yield %0.80.80.91.30.9 
Book value per share (Unadj.) Rs68.085.4101.5101.4126.9 
Adj. book value per shareRs68.085.4101.5101.4126.9 
Shares outstanding (eoy) m1,023.741,023.741,023.741,023.741,023.74 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x4.34.02.92.02.6 
Avg P/E ratio x26.426.920.424.318.4 
P/CF ratio (eoy) x21.120.615.415.313.7 
Price / Book Value ratio x5.65.43.62.83.0 
Dividend payout %22.120.519.330.516.8 
Avg Mkt Cap Rs m391,582470,666378,171286,034393,092 
No. of employees `000NANANANANA 
Total wages/salary Rs m14,85216,44719,03221,69822,548 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ZYDUS LIFESCIENCES INCOME DATA
Net Sales Rs m91,807119,050131,656142,531151,022 
Other income Rs m1,4711,3302,0851,171449 
Total revenues Rs m93,278120,380133,741143,702151,471 
Gross profit Rs m19,01228,28629,68024,16631,335 
Depreciation Rs m3,7335,3885,9866,9657,248 
Interest Rs m6311,1081,9583,4181,688 
Profit before tax Rs m16,11923,12023,82114,95422,848 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,2895,6445,3033,1981,472 
Profit after tax Rs m14,83017,47618,51811,75621,376 
Gross profit margin %20.723.822.517.020.7 
Effective tax rate %8.024.422.321.46.4 
Net profit margin %16.214.714.18.214.2 
ZYDUS LIFESCIENCES BALANCE SHEET DATA
Current assets Rs m60,22382,29784,98187,15487,160 
Current liabilities Rs m53,05860,83073,42582,69478,613 
Net working cap to sales %7.818.08.83.15.7 
Current ratio x1.11.41.21.11.1 
Inventory Days Days4236343533 
Debtors Days Days91981109476 
Net fixed assets Rs m83,02989,110140,147141,183140,943 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m68,57686,421102,839102,733128,899 
Net worth Rs m69,60087,445103,863103,757129,923 
Long term debt Rs m24,68425,55139,49732,1466,095 
Total assets Rs m143,252171,407225,128228,337228,103 
Interest coverage x26.521.913.25.414.5 
Debt to equity ratio x0.40.30.40.30 
Sales to assets ratio x0.60.70.60.60.7 
Return on assets %10.810.89.16.610.1 
Return on equity %21.320.017.811.316.5 
Return on capital %17.821.418.013.518.0 
Exports to sales %00000 
Imports to sales %11.89.48.810.210.5 
Exports (fob) Rs m00000 
Imports (cif) Rs m10,87411,24211,59314,50415,911 
Fx inflow Rs m21,28042,68348,40452,75263,535 
Fx outflow Rs m10,87411,24211,59314,50415,911 
Net fx Rs m10,40631,44136,81138,24847,624 
ZYDUS LIFESCIENCES CASH FLOW
From Operations Rs m 13,117 9,193 12,819 29,315 32,930 
From Investments Rs m -28,719 -9,737 -42,387 -10,123 -7,225 
From Financial Activity Rs m 23,158 515 18,846 -15,282 -25,489 
Net Cashflow Rs m 7,556 -29 -8,109 3,989 -905 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 74.9%
Institution 15.4%
Non-Institution 9.7%
Total 100.0%
Free Float 25.1%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Zydus Corporate Park Scheme No.63, Survey No. 536 Khoraj(gandhinagar) Nr. Vaishnodevi Circle, Sarkhej - Gandhinagar Highway, Ahmedabad - 382481
E-mail investor.grievance@zyduscadila.com/dhavalsoni@zyduscadila.com Web www.zyduscadila.com
Tel 079- 26868100 /26868101 /26868102 /26868103-20/71800000 Fax 079- 26862365/48040000
Sector PHARMACEUTICALS Group Cadila Group
Tr Agent Link Intime India Pvt Ltd., 506-508 5th Floor Amaranth Business Complex - I (ABC - I), Beside Gala Business Center St. Xaviers Corner Off C.G. Road, Navrangpura
Auditor Mukesh M. Shah & Co.
CHM: Pankaj R Patel COMP SEC: Dhaval N Soni YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 1 DIV YIELD (%): 1.0

Read: ZYDUS LIFESCIENCES 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    


Yellow Ad

Advertisement

A One Stock Gift in 1990 Turns into Rs 130 Crores

In 2017, Ravi made headlines by calling a leading business news channel with a surprising announcement - his grandfather had left him 20,000 shares of only one stock.

And on the day of his call - these shares were worth Rs 130 crore.

Can you guess which is this company?

It's MRF.

Ravi's story is one of the amazing stories of becoming Crorepati from a single stock.

But the question is, how to find that one stock with crorepati potential?

To find the answer to this million-dollar question, join our 'One Stock Crorepati' MEGA summit on 30th June, where we will reveal details of what we call a potential 'crorepati' stock...

Learn more



Today's Market

Sensex Zooms 462 Points, Nifty Ends Near 15,700; Auto & FMCG Stocks Rally(Closing)

Indian share markets ended the week on a firm note tracking positive global cues.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling (Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively? (Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover? (Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ZYDUS LIFESCIENCES

  • Track your investment in ZYDUS LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES 8-QTR ANALYSIS

COMPARE ZYDUS LIFESCIENCES WITH

MARKET STATS